Important Information Regarding Rhopressa

Posted in Latest News on June 26, 2018.

During the June 22, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.

Important note, Rhopressa, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided.



More Latest News

Topical Ocular Pharmaceutical Agents added to Formulary
May 27, 2022

The Board of Optometry has added the following Topical Ocular Pharmaceutical Agents to the formulary… Continue reading


Meningococcal Disease and Vaccines
April 14, 2022

The Florida Department of Health (FDOH) is responding to an outbreak of meningococcal disease in some areas of Florida. Continue reading